Entourage Announces Results of 2024 Annual General Meeting of Shareholders
12 Juni 2024 - 9:13PM
Entourage Health Corp.
(
TSX-V:ENTG) (
OTCQX:ETRGF)
(
FSE:4WE) (“
Entourage” or the
“
Company”), a Canadian producer and distributor of
award-winning cannabis products, is pleased to announce that
shareholders overwhelmingly approved all proposed resolutions at
its annual general meeting of shareholders (“AGM”) held virtually
on June 12, 2024.
All director nominees, as listed in the
Management Information Circular dated May 3, 2024, were elected as
directors of the Company, including George Scorsis, Gail Paech,
Bruce Croxon, and Jason Alexander. With a combined average
shareholder approval rating of 97%, all elected directors will
serve on the Company’s board of directors (the “Board”) until the
next AGM or until their successors are elected or
appointed.
Additionally, the Company’s shareholders
re-appointed MNP LLP as Entourage’s auditor to hold office until
the next AGM or until its successor is duly appointed and
authorized the Board to fix its remuneration.
“Over the past year, Entourage has undertaken a
strategic transformation to align our operations with the dynamic
cannabis industry," stated George Scorsis, Executive Chair and CEO.
"As we progress, we extend our gratitude to our shareholders for
their confidence in our vision for sustainable, profitable growth.
I also want to recognize the contributions and support from our
directors as we strive to achieve new milestones and elevate our
company to achieve even greater success."
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent Company of Entourage Brands Corp., a licence holder
producing and distributing cannabis products for the medical and
adult-use markets. The Company owns and operates a fully licensed
26,000F sq. ft. Aylmer, ON processing facility. With its Starseed
Medicinal medical-centric brand, Entourage has expanded its
multi-channelled distribution strategy. Starseed's industry-first,
exclusive partnership with LiUNA, the largest construction union in
Canada, along with employers and union groups, complements
Entourage's direct sales to medical patients. Entourage's elite
adult-use product portfolio includes Color Cannabis, Saturday
Cannabis – and now Dime Bag and Syndicate – sold across eight
provincial distribution agencies. Exclusive Canadian producer and
distributor of award-winning U.S.-based wellness brand Mary's
Medicinals, sold in both medical and adult-use channels. In
addition, Entourage also entered into an exclusive agreement with
Irwin Naturals, a renowned nutraceutical and herbal supplement
formulator of branded wellness products sold across North
America.
Follow Entourage and its brands on:
LinkedIn
Instagram: Color Cannabis,
Saturday Cannabis, Starseed &
Syndicate
For additional information or investor or media
inquiries:Catherine FlamanSenior Director, Communications
& Corporate
Affairs416-910-0279catherine.flaman@entouragecorp.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
Forward Looking Information
This press release contains "forward-looking
information" within the meaning of applicable Canadian securities
legislation which are based upon Entourage's current internal
expectations, estimates, projections, assumptions and beliefs and
views of future events. Forward-looking information can be
identified using forward-looking terminology such as "expect",
"likely", "may", "will", "should", "intend", "anticipate",
"potential", "proposed", "estimate" and other similar words,
including negative and grammatical variations thereof, or
statements that certain events or conditions "may", "would" or
"will" happen, or by discussions of strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions, and views of future events which management believes
to be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance, or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry in Canada generally; the
ability of Entourage to implement its business strategies; the
COVID-19 pandemic; competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities' regulatory authorities on SEDAR+ at
www.sedarplus.ca. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
Entourage Health (TSXV:ENTG)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
Von Dez 2023 bis Dez 2024